Lot and serial number of the device not provided by the complainant; therefore, the udi, expiration and manufacturing dates are not known.Device history record (dhr) review was unable to be conducted for the disposable device as the identification numbers were not provided by the complainant.The device involved in this event was not returned for evaluation purposes therefore visual and functional analysis of the product could not be performed.We are unable to confirm a relationship between the device and the issue reported and a definitive root cause for the reported event could not be determined.The information obtained during complaint investigation will be included in our global complaint trending and product surveillance will continue to monitor complaints of this type for adverse trends.If the product is received or additional information is obtained, the investigation will be reopened accordingly per standard operating procedure.2 devices were involved in this event and are reported under : 1222780-2021-00287.
|
It was reported that on (b)(6) 2021, after a myosure procedure that involved a myosure reach and a myosure xl to remove a calcified fibroid, the procedure went without incidents and had a final deficit of 1600ml ; the patient continued bleeding after the procedure, using two pads in the last hour.Physician decided to administer 1 g of tranexamic acid (txa) 1 g intravenously , the patient continued to heavily bleed and the physician administered methergine and cytotec (misoprostol).The patient´s bleeding slowed but continued.The physician consulted about the possibilty of performing an ablation to stop the bleeding which was considered an off-label use.No other information is available.
|